Global Nuclear Medicine Radioisotopes Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

SKU ID : GIR-GIR1903250059 13793180

Publishing Date : 16-Aug-2019

No. of pages : 121

PRICE
3480
6960


  • Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.

    Scope of the Report:
    The worldwide market for Nuclear Medicine Radioisotopes is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
    This report focuses on the Nuclear Medicine Radioisotopes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    Agfa-Gevaert Group
    Braco
    Cardiarc
    Cardinal Health
    CMR Naviscan (Gamma Medica Inc.)
    Curium
    Digirad
    GE Healthcare
    Nordion (Canada)
    NTP Radioisotopes SOC
    Positron
    Segami
    Siemens Healthcare

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Thallium-201 (Tl-201)
    Iodine (I-123)
    Fluorine-18
    Rubidium-82 (Rb-82)
    Other

    Market Segment by Applications, can be divided into
    Tumor
    Heart Disease
    Lymphoma
    Thyroid Gland
    Other

    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nuclear Medicine Radioisotopes product scope, market overview, market opportunities, market driving force and market risks.
    Chapter 2, to profile the top manufacturers of Nuclear Medicine Radioisotopes, with price, sales, revenue and global market share of Nuclear Medicine Radioisotopes in 2017 and 2018.
    Chapter 3, the Nuclear Medicine Radioisotopes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nuclear Medicine Radioisotopes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
    Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
    Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
    Chapter 12, Nuclear Medicine Radioisotopes market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
    Chapter 13, 14 and 15, to describe Nuclear Medicine Radioisotopes sales channel, distributors, customers, research findings and conclusion, appendix and data source.